Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors.
Rosj GallicchioAlessia GiordanoMariarita MilellaRebecca StortoTeresa PellegrinoAnna NardelliAntonio NappiLuigia TarriconeGiovanni StortoPublished in: Cancer control : journal of the Moffitt Cancer Center (2023)
represents a valuable volumetric parameter able to predict the outcome in GEP-NET patients who underwent surgery. The magnitude of the SSTR representative tumor burden holds a predominant value for determining the response to therapy in GEP-NET patients before surgery, rather than the maximal SSTR representation at single voxel.
Keyphrases
- computed tomography
- positron emission tomography
- end stage renal disease
- neuroendocrine tumors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- pet ct
- prognostic factors
- magnetic resonance imaging
- peritoneal dialysis
- stem cells
- coronary artery bypass
- coronary artery disease
- acute coronary syndrome
- smoking cessation
- image quality